propranolol has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bar-Ilan, A; Beilin, M; Belkin, M; Green, K; Neumann, R | 1 |
Gorzalka, BB; Hill, MN; Morrish, AC; Riebe, CJ | 1 |
2 other study(ies) available for propranolol and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol
Article | Year |
---|---|
Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
Topics: Animals; Aqueous Humor; Blood Pressure; Cannabinoids; Clonidine; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Fluorophotometry; Heart Rate; Injections, Intravenous; Intraocular Pressure; Male; Propranolol; Pupil; Rabbits | 2000 |
Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Cannabinoids; Desipramine; Dronabinol; Female; Male; Norepinephrine; Piperidines; Prazosin; Propranolol; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sex Characteristics; Substance Withdrawal Syndrome; Swimming; Synaptic Transmission | 2009 |